FCM

Farallon Capital Management Portfolio holdings

AUM $15.3B
1-Year Est. Return 51.42%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+51.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.3B
AUM Growth
-$2.87B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
201
New
Increased
Reduced
Closed

Top Buys

1
+$292M
2
+$280M
3
+$248M
4
MA icon
Mastercard
MA
+$138M
5
TMO icon
Thermo Fisher Scientific
TMO
+$133M

Top Sells

1
+$650M
2
+$470M
3
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

1 Healthcare 57.82%
2 Financials 13.96%
3 Technology 12.78%
4 Consumer Discretionary 5.83%
5 Industrials 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNA
101
AleAnna Inc
ANNA
$137M
$650K ﹤0.01%
78,400
ARQT icon
102
Arcutis Biotherapeutics
ARQT
$2.6B
$613K ﹤0.01%
26,000
CELC icon
103
Celcuity
CELC
$4.46B
$457K ﹤0.01%
4,000
LIVN icon
104
LivaNova
LIVN
$3.92B
$381K ﹤0.01%
6,000
TERN
105
DELISTED
Terns Pharmaceuticals
TERN
$369K ﹤0.01%
7,000
-635,000
IONS icon
106
Ionis Pharmaceuticals
IONS
$12.1B
$360K ﹤0.01%
4,800
TVTX icon
107
Travere Therapeutics
TVTX
$4.2B
$357K ﹤0.01%
12,000
GMED icon
108
Globus Medical
GMED
$10.6B
$345K ﹤0.01%
4,000
SRRK icon
109
Scholar Rock
SRRK
$5.35B
$344K ﹤0.01%
7,000
ONC
110
BeOne Medicines Ltd
ONC
$28.5B
$327K ﹤0.01%
1,100
WGS icon
111
GeneDx Holdings
WGS
$1.57B
$321K ﹤0.01%
5,000
-65,000
COR icon
112
Cencora
COR
$51.5B
$314K ﹤0.01%
1,000
NUVL icon
113
Nuvalent
NUVL
$7.12B
$307K ﹤0.01%
3,000
PGNY icon
114
Progyny
PGNY
$1.96B
$306K ﹤0.01%
18,000
STOK icon
115
Stoke Therapeutics
STOK
$1.79B
$293K ﹤0.01%
9,000
ERAS icon
116
Erasca
ERAS
$4.1B
$291K ﹤0.01%
+18,000
EHC icon
117
Encompass Health
EHC
$10.1B
$290K ﹤0.01%
3,000
-231,500
NKTR icon
118
Nektar Therapeutics
NKTR
$2B
$288K ﹤0.01%
+4,000
GKOS icon
119
Glaukos
GKOS
$6.51B
$280K ﹤0.01%
2,600
MIRM icon
120
Mirum Pharmaceuticals
MIRM
$5.6B
$277K ﹤0.01%
3,000
SBRA icon
121
Sabra Healthcare REIT
SBRA
$4.68B
$269K ﹤0.01%
14,000
KRYS icon
122
Krystal Biotech
KRYS
$8.64B
$258K ﹤0.01%
1,000
-1,000
OMER icon
123
Omeros
OMER
$735M
$243K ﹤0.01%
23,000
ALMS
124
Alumis Inc
ALMS
$2.55B
$242K ﹤0.01%
+11,000
APLS
125
DELISTED
Apellis Pharmaceuticals
APLS
$241K ﹤0.01%
+6,000
3 4
5
6 7